Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for arterial wall inflammation in chronic kidney disease
NL-OMON45991Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of atorvastatin in atherosclerosis and chronic kidney disease (CKD), sponsored by Amsterdam University Medical Center. Primary endpoint: Change in target-to-background ratio. Started Nov 2016; status: active, not recruiting.
02
Drugs
atorvastatin
03
Conditions
atherosclerosischronic kidney disease (CKD)
Beyond the preview
Go deeper on NL-OMON45991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45991.